ACM
ANAB icon

Asymmetry Capital Management’s AnaptysBio ANAB Stock Holding History

Asymmetry Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-33,211
Closed -$3.31M – 25
2018
Q3 		$3.31M Sell
33,211
-7,507
-18% -$623K 3.06% 13
2018
Q2 		$2.89M Buy
+40,718
New +$3.42M 2.84% 12

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Asymmetry Capital Management's ANAB Position: Q4 2018 in Review

Asymmetry Capital Management sold out of AnaptysBio (ANAB) in Q4 2018, closing a stake of 33,211 shares — an estimated $3.31M sold.

Asymmetry Capital Management first reported a position in ANAB in Q2 2018 and held it in 2 quarters. The position peaked at $3.31M in Q3 2018. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2018.

  • Asymmetry Capital Management reported no remaining AnaptysBio position as of Q4 2018 after selling out during the quarter.
  • Asymmetry Capital Management sold 33,211 AnaptysBio shares in Q4 2018, an estimated $3.31M.
  • Asymmetry Capital Management first reported a position in AnaptysBio in Q2 2018 and held it in 2 quarters.
  • Asymmetry Capital Management's AnaptysBio position peaked at $3.31M in Q3 2018.
  • 121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2018.

Based on Asymmetry Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.